<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00893724</url>
  </required_header>
  <id_info>
    <org_study_id>FF0901</org_study_id>
    <nct_id>NCT00893724</nct_id>
  </id_info>
  <brief_title>Supplemental Adjuvants for Intracellular Nutrition and Treatment</brief_title>
  <acronym>SAINTS</acronym>
  <official_title>The Effect of Supplemental Adjuvants for Intracellular Nutrition and Treatment on Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mid-Atlantic Retina Consultations, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>West Virginia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mid-Atlantic Retina Consultations, Inc.</source>
  <brief_summary>
    <textblock>
      Nutritional supplements have an augmentative effect on the outcomes of standard treatment of
      diabetic macular edema (DME) and Neovascular Age-Related Macular Degeneration (NAMD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It has been shown that in chronic diseases, oxidative stress results from Nitric acid
      reacting with oxygen to form toxins that damage both somatic and mitochondrial DNA. The
      potential for protecting the DNA and promoting repair by using nutritional supplements will
      be tested by augmenting standard treatments for DME and NAMD with such supplements. The
      patients will be randomized to treatment group and placebo group and followed up for a year
      in a double masked fashion. Anatomic and visual outcomes, as well as side effects will be
      assessed and analyzed. If the results are promising, this pilot study can be used to design
      alternative (cheaper, better and longer lasting) treatments for DME, NAMD and perhaps other
      chronic illnesses.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of regression (Optical Coherence Tomography)</measure>
    <time_frame>Monthly</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of regression (Optical Coherence Tomography)</measure>
    <time_frame>Monthly</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual change (ETDRS)</measure>
    <time_frame>Monthly</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect on HbA1C</measure>
    <time_frame>Monthly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect on Blood pressure</measure>
    <time_frame>Monthly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect on serum uric acid</measure>
    <time_frame>Monthly</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Neovascular Age-related Macular Degeneration</condition>
  <condition>Diabetic Macular Edema</condition>
  <arm_group>
    <arm_group_label>P (Placebo)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>S (Supplement)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SM (Supplement with Minocycline)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neutral pills with no medicinal effect</intervention_name>
    <description>Neutral pills with no medicinal effect</description>
    <arm_group_label>P (Placebo)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Inosine; Tocopherols, Tocotrienol, CoQ10 combination capsule; Niacinamide SR; Viatmin C; N-acetyl Cysteine; Complete Multivitamin with all minerals</intervention_name>
    <description>Inosine [SR] - 1[500mg] tablet bid Tocopherols [200IU], Tocotrienol [10mg], CoQ10 [50mg] - combination capsule bid Sustained Release Niacinamide - 1 [750mg] tablet bid Vitamin C - 1 [1000mg] sustained release tablet bid N-acetyl Cysteine - 1 [600mg] sustained release tablet qd Complete Multivitamin with all minerals - 1 tablet (sustained release) bid</description>
    <arm_group_label>S (Supplement)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inosine; Tocopherol, Tocotrienol, CoQ10 combination capsule; Niacinamide; Vitamin C; N-acetyl Cysteine; Complete Multivitamin with all minerals; Minocycline</intervention_name>
    <description>Inosine [SR] - 1 [500mg] tablet bid Tocopherol [200IU], Tocotrienol [10mg], CoQ10 [50mg] combination capsule bid Sustained Release Niacinamide 1 [750mg] tablet bid Vitamin C 1 [1000mg] sustained release tablet bid N-acetyl Cysteine 1 [600mg] sustained release tablet qd Complete Multivitamin with all minerals - 1 tablet (sustained release) bid Minocycline 1 [50mg] tablet qd</description>
    <arm_group_label>SM (Supplement with Minocycline)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical Diagnosis of NAMD

          -  Clinical Diagnosis of DME

        Exclusion Criteria:

          -  Pregnant Women

          -  Known allergy to any component used in the treatment combinations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nabil M Jabbour, MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.A.R.C.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mid-Atlantic Retina Consultations, Inc.</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2009</study_first_submitted>
  <study_first_submitted_qc>May 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2009</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Nabil M. Jabbour, MD, FACS/ Principal Investigator</name_title>
    <organization>Mid-Atlantic Retina Consultations, Inc.</organization>
  </responsible_party>
  <keyword>DME</keyword>
  <keyword>NAMD</keyword>
  <keyword>Oxidative damage</keyword>
  <keyword>Nutritional supplements/vitamins</keyword>
  <keyword>DNA repair</keyword>
  <keyword>NAMD/wet AMD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Wet Macular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Coenzyme Q10</mesh_term>
    <mesh_term>Niacinamide</mesh_term>
    <mesh_term>Niacin</mesh_term>
    <mesh_term>Nicotinic Acids</mesh_term>
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
    <mesh_term>Ubiquinone</mesh_term>
    <mesh_term>Minocycline</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 24, 2013</submitted>
    <returned>December 13, 2013</returned>
    <submitted>October 24, 2014</submitted>
    <returned>October 28, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

